BSEAGM/EGM10 Aug 2026 · 10 Aug 2026, 04:55 pm

Scrutinizers Report Pertaining to Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23rd 2026.

Bal Pharma Ltd · 524824

✦ AI SummaryResults

Bal Pharma Ltd's scrutinizer's report on postal ballot voting has been submitted, with no rejections or modifications received from shareholders after the issuance of a corrigendum. The voting process was conducted electronically, and the results will be considered as the final voting.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bal Pharma Ltd - 524824 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Attachments (1)

📄

564e344f-2a52-4997-a800-9486d3b07702.pdf

pdf

Download →
View document text
To To Date: August 10, 2026 Listing Compliance Department BSE Limited National Stock Exchange of India Limited, 1st Floor, New Trading Ring, Exchange Plaza, 5th Floor, Plot No. C/2, G Block, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai-400051 Mumbai – 400001 Symbol: BALPHARMA Scrip Code: 524824 Sub: Scrutinizer's Report on the result of the Postal Ballot Voting (remote e-voting). Dear Sir/Madam, With reference to our earlier intimation dated July 09, 2026 regarding the Postal Ballot Notice of the Company, read together with its Corrigendum dated July 23, 2026, and pursuant to Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mr. Parameshwar Bhat, Practicing Company Secretary (M. No.11004) Bangalore, was appointed as the scrutinizer of poll for conducting the postal ballot process and has submitted his report on Monday 10th August 2026. Scrutinizer's Report on the result of the Postal Ballot received from shareholders only through the electronic voting process (remote e-voting) is enclosed along with the register showing the particulars of the e-votes registered on the National Securities Depository Limited ('NSDL') e-voting system in respect of the said Resolutions. The aforesaid documents are also being made available on the website of the Company. You are requested to kindly take the same on your records Thanking You. For Bal Pharma Ltd Shreepada ML Company Secretary and Compliance officer ICSI M No : A66681 Enclosure: As above PARAMESHWAR G. BHAT # 496/4, II Floor, 10th Cross B.Com., LLB, ML, MBA, FCS Near Bashyam Circle, Sadashivanagar, Bangalore - 560 080 Company Secretary Tel : +91 80 23610847 Telefax ; +91 80 41231106 e-mail : parameshwar@vjkt.in parameshwar.g.bhat@gmail.com REPORT OF SCRUTINIZER ON E-VOTING AND POSTAL BALLOT PROCESS Private & Confidential {Strictly to the addressee only} 10 August, 2026 Mr. ShaileshSiroya Managing Director Bal Pharma Limited (CIN: L85110KA1987PLC008368) 21 & 22, Bommasandra Industrial Area, Bommasandra Industrial Estate, Bengaluru- 560099, Karnataka, India Dear Sir, |, Parameshwar G. Bhat, Company Secretary in Whole-Time Practice (FCS No 8860, CP No.11004), having Office at # 496/4, 2™ Floor, 10" Cross, Near Bashyam Circle, Sadashivanagar, Bengaluru — 560080, was duly appointed as Scrutinizer by the Company for the purpose of scrutinizing the Postal Ballot undertaken by your Company vide Notice dated 9'" July,2026, facility provided as per Sections 108 and 110 of the Companies Act, 2013 (‘the Act’), read with Rules 20 and 22 of the Companies (Management and Administration) Rules, 2014 as amended from time to time (‘the Rules’) and various circulars issued by the Ministry of Corporate Affairs (MCA) namely, Circular No.19/2021 dated December 8, 2021 read with Circular No.14/2020 dated April 8, 2020, Circular No.17/2020 dated April 13, 2020, Circular No. 20/2020 dated May 5, 2020, Circular No. 02/2021 dated January 13, 2021, Circular No. 03/2022 dated May 5, 2022, General Circular No. 11/2022 dated December 28, 2022, General Circular No. 09/2024 dated September 19, 2024 and read with other relevant circulars issued in this regard the latest being General Circular No. 03/2025 dated September 22, 2025 (collectively referred to as "MCA Circulars") and the provisions of Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. My responsibility as Scrutinizer is to ensure that the voting process is conducted in a fair and transparent manner and is restricted to make a Scrutinizer’s Report for the votes cast in “favour” or “against” on the resolution proposed in the Notice dated 9" July, 2026based on the report provided by National Securities Depository Limited (NSDL), the Agency engaged by the Company to provide e-voting facility up to 8" August, 2026 (5.00 P.M. IST). Further, the Company issued a Corrigendum dated 23™ July, 2026to the Notice dated 9g" July, 2026 (Original Notice), which shall form an integral part of the Original Notice and the Explanatory Statement annexed thereto and shall be read in conjunction with the Original Notice. The Company informed all the members of the Company that the members who have already cast their votes in the ongoing Postal Ballot i.e. after the start of e-Voting but prior to receiving this Corrigendum to the Original Notice, and if they wish to modify their votes in light of the information provided in the Corrigendum, they can do so by writing an email to the scrutinizer at the following email address parameshwar@vijkt.inwith a copy marked to evoting@nsdl.comon or before 05.00 P.M. (IST) on Saturday, August 8, 2026. In terms of the aforesaid Original Notice read with Corrigendum and as per the provisions of the Act and the Rules, e-voting was kept open from Friday, 10" July, 2026 (9.00 A.M IST) till Saturday,8"" August, 2026 (5.00 P.M IST) and Members were requested to cast their votes electronically conveying their assent or dissent in respect of the Resolution on the e-voting platform. | was not in receipt of rejection/modification/comments from any member(s), post issuance of the Corrigendum dated 23% July, 2026 till 8'" August, 2026 (5.00 P.M. IST). As per the information received from the Company/NSDL, neither the Company nor the National Securities Depository Limited (NSDL) on evoting@nsdl.com, were in receipt of any rejection/modification/comments from any member(s), post issuance of the Corrigendum dated 23" July, 2026 till 8" August, 2026 (5.00 P.M. IST). Hence, the votes casted by the Members as per the report generated from the e-voting website of National Securities Depository Limited (NSDL) was considered as the final voting. The details containing inter-alia, the list of the Members, who voted “for” or “against” on the Resolution that was put to vote, was derived from the report generated from the e-voting website of National Securities Depository Limited (NSDL) ie. https://evoting.nsdl.com and based on such reports, a. 99 (Ninety Nine) members (folio wise) have cast their votes through remote e- voting. On verification of 99 (Ninety Nine) members voting through e-Voting, up to 8"" August, 2026 (5.00 P.M IST)from the Shareholders of Bal Pharma Limi patding Equity Shares and based on the information made available to me, | hereby submit my Report on the results of the Postal Ballot, as follows: VOTING ANALYSIS: SPECIAL BUSINESS: ITEM NO. 1._To consider the issue of 10,00,000 Warrants to the Promoter of the company on preferential basis. SPECIAL RESOLUTION: Particulars No. of votes contained in Remote E-voting No. of members No. of Votes cast % Total Valid Votes voted (Shares) Cast Assent 86 8155799 99.96 Dissent 13 3264 0.04 Total 99 8159063 100.00 Invalid / NIL NA NA Abstained Based on the above information, you may kindly declare the results and take steps accordingly. Thanking you Yours faithfully Practicing Company Secretary Membership No.: 8860 CP No.: 11004 Scrutinizer Peer Review No.:5508/2024 UDIN: F008860H001062748